Key Insights

Highlights

Success Rate

100% trial completion (above average)

Treatment Research

5 treatments under study, led by Gastric Fundal Mucosal Ablation Gfma

Related Conditions

Often studied with 19 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 7 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 4 completed with results

Key Signals

100% success

Data Visualizations

Phase Distribution

3Total
Not Applicable (3)

Trial Status

Completed4
Recruiting2
Not Yet Recruiting1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 4 completed trials

Clinical Trials (7)

Research Network

Common Treatments

  • Gastric Fundal Mucosal Ablation Gfma1
  • Gastric Mucosal Ablation Gma1
  • Threshold Financial Incentive1
  • Control1
  • Proportional Financial Incentive1

Active Sponsors

  • University of California, San Francisco4
  • Dr. Christopher McGowan2
  • Ministry of Health, France1
  • Assistance Publique - Hôpitaux de Paris1

Top Investigators

Related Conditions

  • Clinically Severe Obesity4
  • Obesity And Obesityrelated Medical Conditions2
  • Obesity Prevention2
  • Obesity And Overweight2
  • Inadequate Initial Weight Loss2

Activity Timeline